Occult hepatitis B virus and hepatitis C virus infections

被引:51
作者
Carreno, Vicente [1 ]
Bartolome, Javier [1 ]
Castillo, Inmaculada [1 ]
Quiroga, Juan Antonio [1 ]
机构
[1] Fdn Estudio Hepatitis Virales, Madrid 28015, Spain
关键词
D O I
10.1002/rmv.569
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Occult HBV infection is a well-recognised clinical entity characterised by the detection of HBV-DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen (HBsAg). Occult HBV infection has been described not only in patients who have resolved an acute or chronic HBV infection but also in patients without any serological markers of a past HBV infection. Occult HBV infection in patients with chronic HCV infection may induce more severe liver disease and lower response rate to interferon treatment. The existence of occult HCV infections has been also reported more recently. Occult HCV infection is characterised by the presence of HCV-RNA in liver and peripheral blood mononuclear cells in the absence of detectable serum HCV-RNA. Occult HCV infection may occur under two different clinical situations: in hepatitis C antibody-(anti-HCV) negative and serum HCV-RNA-negative patients with abnormal liver function tests and in anti-HCV-positive patients who have no detectable serum HCV-RNA and who have normal liver enzymes. The clinical relevance of occult HCV infections is still under investigation. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:139 / 157
页数:19
相关论文
共 147 条
[1]   Failure to diagnose recent hepatitis C virus infections in London injecting drug users [J].
Aarons, E ;
Grant, P ;
Soldan, K ;
Luton, P ;
Tang, J ;
Tedder, R .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (04) :548-553
[2]  
Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93
[3]  
Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44
[4]   Replication of hepatitis C virus [J].
Bartenschlager, R ;
Lohmann, V .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :1631-1648
[5]   Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C [J].
Bartolome, Javier ;
Manuel Lopez-Alcorocho, Juan ;
Castillo, Inmaculada ;
Rodriguez-Inigo, Elena ;
Antonio Quiroga, Juan ;
Palacios, Ricardo ;
Carreno, Vicente .
JOURNAL OF VIROLOGY, 2007, 81 (14) :7710-7715
[6]   Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology [J].
Berasain, C ;
Betés, M ;
Panizo, A ;
Ruiz, J ;
Herrero, JI ;
Civeira, MP ;
Prieto, J .
GUT, 2000, 47 (03) :429-435
[7]   Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection [J].
Besisik, F ;
Karaca, Q ;
Akyüz, F ;
Horosanli, S ;
Önel, D ;
Badur, S ;
Sever, MS ;
Danalioglu, A ;
Demir, K ;
Kaymakoglu, S ;
Çakaloglu, Y ;
Ökten, A .
JOURNAL OF HEPATOLOGY, 2003, 38 (04) :506-510
[8]   Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation [J].
Bläckberg, J ;
Kidd-Ljunggren, K .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :992-997
[9]   Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection [J].
Boni, C ;
Amadei, B ;
Urbani, S ;
Fisicaro, P ;
Zerbini, A ;
Mori, C ;
Missale, G ;
Bertoni, R ;
Azzurri, A ;
Del Prete, G ;
Ferrari, C .
HEPATOLOGY, 2004, 40 (02) :289-299
[10]   Impact of HBV HCV and GBV-C/HGV on hepatocellular carcinomas in Europe:: results of a European concerted action [J].
Bréchot, C ;
Jaffredo, F ;
Lagorce, D ;
Gerken, G ;
zum Büschenfelde, KM ;
Papakonstontinou, A ;
Hadziyannis, S ;
Romeo, R ;
Colombo, M ;
Rodes, J ;
Bruix, J ;
Williams, R ;
Naoumov, N .
JOURNAL OF HEPATOLOGY, 1998, 29 (02) :173-183